ImpediMed Limited at it's general meeting approved removal of Donald Williams as a director of the Company, removal of Amit Patel as a director of the Company, removal of David Anderson as a director of the Company, removal of Daniel Sharp as a director of the Company with effect from September 28, 2023, appointment of McGregor Grant as a director of the Company with effect from September 28, 2023, appointment of Christine Emmanuel-Donnelly as a director of the Company, appointment of Andrew Grant as a director of the Company and appointment of Janelle Delaney as a director of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.078 AUD | -1.27% | -8.24% | -46.21% |
Apr. 30 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
Apr. 30 | Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.21% | 109M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.28% | 65.01B | |
+15.38% | 53.02B | |
+3.64% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- IPD Stock
- News ImpediMed Limited
- Impedimed Limited Announces Board Changes